Whitecap Biosciences, LLC Report issue

For profit Phase 2
Founded: Laguna Hills CA United States (2015)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2019
NCT04149899
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Whitecap Biosciences, LLC

Active Ingredients

Drugs in Phase 2 Trials (1)

timolol (blocadren) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 2)

Glaucoma, Open-Angle (Phase 2)

Hypertension (Phase 2)

Ocular Hypertension (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1